Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-021837
Filing Date
2013-04-17
Accepted
2013-04-17 17:06:53
Documents
1
Period of Report
2013-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10076
  Complete submission text file 0001209191-13-021837.txt   11510
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Issuer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SALIX PHARMACEUTICALS, LTD. 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address
KEANE WILLIAM P (Reporting) CIK: 0001204286 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23265 | Film No.: 13767450